Gastric Cancer | GEN - Genetic Engineering and Biotechnology News

Gastric Cancer

Amgen to Acquire Five Prime for $1.9B, Adding Phase III Gastric Cancer Candidate

single cell analysis

Gastric Cancer

Single-Cell Transcriptome Profiling of Gastric Tumors Reveals Prognostic Gene Signature

Gastric Cancer

Five Prime Eliminates 70 Jobs in Restructuring

Gastric Cancer

Boehringer Ingelheim, Lupin Launch $700M+ Cancer Therapy Collaboration Targeting KRAS

Gastric Cancer

Celgene Scraps $2.6B Deal, Licenses Jounce Antibody in Restructured Cancer Collaboration

Gastric Cancer

BioNTech Boosting Pipeline, Manufacturing, Global Presence with $325M in Series B...

Gastric Cancer

Dire Consequence of Persistent Heartburn Drug Use

Gastric Cancer

AstraZeneca, Daiichi Sankyo Launch Potentially $6.9B+ Collaboration to Develop Cancer ADC

Gastric Cancer

Redx Halts Enrollment in Trial of Lead Candidate, Citing Adverse Events

Gastric Cancer

Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...

Gastric Cancer

Sumitomo Dainippon Cancer Stemness Inhibitor Napabucasin Disappoints in Phase III

Gastric Cancer

Roche’s Kadcyla Fails Phase II/III Trial for Gastric Cancer

Gastric Cancer

Adhesin Structure Shows How H. pylori Hangs on for Dear Life

Gastric Cancer

Amgen Halts Rilotumumab Trials in Advanced Gastric Cancer

Gastric Cancer

BMS Signs Up to $475M Option to Acquire F-star’s FS102

12 Page 1 of 2